FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gunnar Oberg

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Living Beings

Infants

Co-author Network

Publications

TOP 3
Michael Grövdal; Mohsen Karimi; Rasheed Khan; Anni Aggerholm; Petar Antunovic; Jan Astermark; Per Bernell; Lena-Maria Engström; Lars Kjeldsen; Olle Linder; Lars Nilsson; Anna Olsson; Mette S Holm; Jon Magnus Tangen; Jonas Wallvik; Gunnar Oberg; Peter Hokland; Sten E Jacobsen; Anna Porwit; Eva Hellström-Lindberg
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.
Jan Fagius; J Lundgren; Gunnar Oberg
Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.
Hans W Axelson; Gunnar Oberg; Håkan Askmark
Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gunnar Oberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Michael Grövdal; Mohsen Karimi; Rasheed Khan; Anni Aggerholm; Petar Antunovic; Jan Astermark; Per Bernell; Lena-Maria Engström; Lars Kjeldsen; Olle Linder; Lars Nilsson; Anna Olsson; Mette S Holm; Jon Magnus Tangen; Jonas Wallvik; Gunnar Oberg; Peter Hokland; Sten E Jacobsen; Anna Porwit; Eva Hellström-Lindberg
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.
British journal of haematology 2010;150(3):293-302.
2009: Jan Fagius; J Lundgren; Gunnar Oberg
Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(2):229-37.
2009: Hans W Axelson; Gunnar Oberg; Håkan Askmark
Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP.
BMJ case reports 2009;2009():.
2007: Michael Grövdal; Rasheed Khan; Anni Aggerholm; Petar Antunovic; Jan Astermark; Per Bernell; Lena-Maria Engström; Lars Kjeldsen; Olle Linder; Lars Nilsson; Anna Olsson; Jonas Wallvik; Jon Magnus Tangen; Gunnar Oberg; Sten Eirik W Jacobsen; Peter Hokland; Anna Porwit; Eva Hellström-Lindberg
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):7107-12.
2006: Ulla Olsson-Strömberg; Mattias Höglund; Magnus Björkholm; Inger Braide; Kristina Carlson; Gösta Gahrton; Gunnar Grimfors; Robert Hast; Rickard Lerner; Olle Linder; Per Ljungman; Eva Löfvenberg; Claes Malm; Per-Gunnar Nilsson; Christer Paul; Stig Rödjer; Leif Stenke; Ulf Tidefeldt; Ingemar Turesson; Ann-Marie Uden; Ake Wahlin; Lars Vilen; Ingemar Winqvist; Olle Zettervall; Gunnar Oberg; Bengt Simonsson
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
Leukemia & lymphoma 2006;47(9):1768-73.
2006: Per Anders Broliden; Inger Marie S Dahl; Robert Hast; Bertil Johansson; Eeva Juvonen; Lars Kjeldsen; Anna Porwit-MacDonald; Malvin Sjoo; Jon Magnus Tangen; Bertil Uggla; Gunnar Oberg; Eva Hellstrom-Lindberg
Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Haematologica 2006;91(5):667-70.
2005: Bengt Simonsson; Gunnar Oberg; Mats Bjoreman; Magnus Bjorkholm; Jan Carneskog; Karin Karlsson; Gösta Gahrton; Gunnar Grimfors; Robert Hast; Hans Karle; Olle Linder; Per Ljungman; Johan Lanng Nielsen; Jonas Nilsson; Eva Lofvenberg; Claes Malm; Karin Olsson; Ulla Olsson-Stromberg; Christer Paul; Leif Stenke; Jesper Stentoft; Ingemar Turesson; Ann-Mari Udén; Ake Wahlin; Lars Vilén; Ole Weis-Bjerrum
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up.
Acta haematologica 2005;113(3):155-62.
2004: Ulla Olsson-Strömberg; Bengt Simonsson; Tomas Ahlgren; Magnus Björkholm; Karin Carlsson; Gösta Gahrton; Robert Hast; Eva Löfvenberg; Olle Linder; Per Ljungman; Claes Malm; Christer Paul; Stig Rödjer; Ingemar Turesson; Ann-Mari Udén; Ake Wahlin; Andreas Killander; Bengt Wadman; Jan Westin; Olle Vikrot; Olle Zettervall; Gunnar Oberg
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(6):462-6.
2003: Robert Hast; Eva Hellström-Lindberg; L Ohm; Magnus Björkholm; Fredrik Celsing; Inger Marie S Dahl; Ingunn Dybedal; Gösta Gahrton; G Lindberg; Richard Lerner; Olle Linder; Eva Löfvenberg; H Nilsson-Ehle; Christer Paul; Jan Samuelsson; Jon Magnus Tangen; Ulf Tidefelt; Ingemar Turesson; Ake Wahlin; Jonas Wallvik; Ingemar Winquist; Gunnar Oberg; Per Bernell
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.
Leukemia 2003;17(9):1827-33.
2003: Eva Hellström-Lindberg; Nina Gulbrandsen; Greger Lindberg; Tomas Ahlgren; Inger Marie S Dahl; Ingunn Dybedal; Gunnar Grimfors; Eva Hesse-Sundin; Martin Hjorth; Lena Kanter-Lewensohn; Olle Linder; Michaela Luthman; Eva Löfvenberg; Gunnar Oberg; Anna Porwit-MacDonald; Anders Rådlund; Jan Samuelsson; Jon Magnus Tangen; Ingemar Winquist; Finn Wisloff
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.
British journal of haematology 2003;120(6):1037-46.
2002: Gunnar Oberg; A Killander; M Björeman; Gösta Gahrton; Gunnar Grimfors; Astrid Gruber; Robert Hast; Richard Lerner; Jan Liliemark; S Mattson; Christer Paul; Bengt Simonsson; A-M Stalfelt; Leif Stenke; Ulf Tidefelt; Ann-Mari Udén; Magnus Björkholm
Long-term follow-up of patients >or=60 yr old with acute myeloid leukaemia treated with intensive chemotherapy.
European journal of haematology 2002;68(6):376-81.
2000: Mia Furebring; Gunnar Oberg; Jan Sjölin
Side-effects of amphotericin B lipid complex (Abelcet) in the Scandinavian population.
Bone marrow transplantation 2000;25(3):341-3.
1999: Karlis Pauksen; Jan Sjölin; A Linde; B Andersson; R Lenkei; Gunnar Oberg; Per Ljungman
Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients.
Scandinavian journal of infectious diseases 1999;31(1):43-9.
1998: V Hamarström; Karlis Pauksen; H Svensson; Gunnar Oberg; C Paul; Per Ljungman
Tetanus immunity in patients with hematological malignancies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(5):469-72.
1998: V Hammarström; Karlis Pauksen; Bo Björkstrand; Bengt Simonsson; Gunnar Oberg; Per Ljungman
Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients.
Bone marrow transplantation 1998;22(1):67-71.
1998: Eva Hellström-Lindberg; Tomas Ahlgren; Y Beguin; M Carlsson; Jan Carneskog; Inger Marie S Dahl; Ingunn Dybedal; Gunnar Grimfors; Lena Kanter-Lewensohn; Olle Linder; Michaela Luthman; Eva Löfvenberg; H Nilsson-Ehle; Jan Samuelsson; Jon Magnus Tangen; I Winqvist; Gunnar Oberg; Anders Osterborg; Ake Ost
Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients.
Blood 1998;92(1):68-75.
1997: Per Ljungman; M Hassan; A N Békássy; Olle Ringdén; Gunnar Oberg
High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1997;20(11):909-13.
1997: Ake Wahlin; Lorentz Brinch; Per Hörnsten; Stein Evensen; Gunnar Oberg; Bengt Simonsson; Michael Hedenus
Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.
European journal of haematology 1997;58(4):233-40.
1997: Seija Grenman; B Tholander; Kari Remes; Marjut Kauppila; Allan Rajamäki; Tarja-Terttu Pelliniemi; Virpi Rantanen; Tuula Salmi; K Carlsson; M Hóglund; Gunnar Oberg; B Simonson; T Salmi
High-dose chemotherapy with autologous stem cell support for the treatment of advanced ovarian cancer--initial experience in Uppsala and Turku.
Acta obstetricia et gynecologica Scandinavica 1997;76(4):363-8.
1996: Per Ljungman; Gunnar Oberg; Johan Aschan; A Ehrnst; B Lönnqvist; Karlis Pauksen; P Sulila
Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1996;18(3):565-8.
1996: Bengt Simonsson; Gunnar Oberg; M Björeman; Magnus Björkholm; Jan Carneskog; Gösta Gahrton; Robert Hast; H Karl; J Lanng-Nielsen; E Löfvenberg; Claes Malm; Ingemar Turesson; A M Udén; L Vilén; O Weis-Bjerrum
Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.
Bone marrow transplantation 1996;17 Suppl 3():S63-4.
1995: Karlis Pauksen; A Linde; Per Ljungman; P Bolme; Gudmar Lönnerholm; Gunnar Oberg; Jan Sjölin
Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation.
Bone marrow transplantation 1995;16(6):807-13.
1995: Per Ljungman; M Hassan; A N Békássy; Olle Ringdén; Gunnar Oberg
Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants.
Bone marrow transplantation 1995;15(6):869-71.
1994: Kristina Carlson; L Bäcklund; B Smedmyr; Gunnar Oberg; Bengt Simonsson
Pulmonary function and complications subsequent to autologous bone marrow transplantation.
Bone marrow transplantation 1994;14(5):805-11.
1994: Jörgen Kristensen; Peter Nygren; Jan Liliemark; H Fridborg; A Killander; Bengt Simonsson; Gunnar Oberg; Rolf Larsson
Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
Leukemia 1994;8(10):1712-7.
1994: H Fridborg; B Jonsson; Peter Nygren; K Csoka; Kenneth Nilsson; Gunnar Oberg; Jörgen Kristensen; Jonas Bergh; B Tholander; L Olsen
Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
British journal of cancer 1994;70(1):11-7.
1994: Johan Arvidson; L E Bratteby; Kristina Carlson; H Hagberg; A Kreuger; Bengt Simonsson; B Smedmyr; A Taube; Gunnar Oberg; Gudmar Lönnerholm
Pulmonary function after autologous bone marrow transplantation in children.
Bone marrow transplantation 1994;14(1):117-23.
1994: Karlis Pauksen; V Hammarström; Per Ljungman; Jan Sjölin; Gunnar Oberg; Gudmar Lönnerholm; L Magnius; Bengt Simonsson
Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(4):547-52.
1994: M Höglund; Bengt Simonsson; B Smedmyr; Gunnar Oberg; Per Venge
The effect of rGM-CSF on neutrophil and eosinophil regeneration after ABMT as monitored by circulating levels of granule proteins.
British journal of haematology 1994;86(4):709-16.
1994: M Carlson; Gunnar Oberg; C Peterson; Per Venge
Releasability of human hypereosinophilic eosinophils is related to the density of the cells.
British journal of haematology 1994;86(1):41-7.
1994: Bengt Simonsson; Gunnar Oberg; A Killander; M Björeman; Magnus Björkholm; Gösta Gahrton; Leif Stenke; Ingemar Turesson; A M Udén; Claes Malm
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-group.
Bone marrow transplantation 1994;14 Suppl 3():S55-6.
1993: H Hagberg; A Berglund; Kristina Carlson; B Glimelius; M Höglund; Gudmar Lönnerholm; U Martinsson; Bengt Simonsson; B Smedmyr; Gunnar Oberg
[Malignant lymphoma. Experiences with autologous bone marrow transplantation in 50 patients].
Läkartidningen 1993;90(45):3950-3.
1993: Bengt Simonsson; Gunnar Oberg; A Killander; M Björeman; M Börkholm; Gösta Gahrton; Robert Hast; Ingemar Turesson; A M Udén; Claes Malm
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.
Stem cells (Dayton, Ohio) 1993;11 Suppl 3():73-6.
1993: V Hammarström; Karlis Pauksen; J Azinge; Gunnar Oberg; Per Ljungman
Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1993;1(4):195-9.
1993: B Lönnqvist; Jan Palmblad; Per Ljungman; Gunnar Grimfors; M Järnmark; R Lerner; C Nyström-Rosander; Gunnar Oberg
Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1993;1(3):139-44.
1993: Kristina Carlson; B Smedmyr; H Hagberg; Gunnar Oberg; Bengt Simonsson
Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas.
Bone marrow transplantation 1993;11(3):205-8.
1993: M Hassan; Gunnar Oberg; M Björkholm; Inger Wallin; M Lindgren
Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.
Cancer chemotherapy and pharmacology 1993;33(3):181-6.
1992: Kristina Carlson; Gudmar Lönnerholm; B Smedmyr; Gunnar Oberg; Bengt Simonsson
Thyroid function after autologous bone marrow transplantation.
Bone marrow transplantation 1992;10(2):123-7.
1992: Karlis Pauksen; V Duraj; Per Ljungman; Jan Sjölin; Gunnar Oberg; Gudmar Lönnerholm; E Fridell; B Smedmyr; Bengt Simonsson
Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
Bone marrow transplantation 1992;9(6):427-32.
1992: Jan Palmblad; B Lönnqvist; B Carlsson; Gunnar Grimfors; M Järnmark; R Lerner; Per Ljungman; C Nyström-Rosander; B Petrini; Gunnar Oberg
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias.
Journal of internal medicine 1992;231(4):363-70.
1992: M Bengtsson; B Simonsson; K Carlsson; B Nilsson; B Smedmyr; B Termander; Gunnar Oberg; Thomas H Tötterman
Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia.
Transplantation 1992;53(4):882-8.
1992: M Hassan; Gunnar Oberg; K Ericson; Hans Ehrsson; L Eriksson; M Ingvar; Sharon Stone-Elander; J O Thorell; B Smedmyr; N Warne
In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patient.
Cancer chemotherapy and pharmacology 1992;30(2):81-5.
1992: Jan Samuelsson; B Lönnqvist; Jan Palmblad; Gunnar Grimfors; M Järnmark; R Lerner; Per Ljungman; C Nyström-Rosander; Gunnar Oberg
Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden.
Scandinavian journal of infectious diseases 1992;24(1):89-96.
1992: Bengt Simonsson; Gunnar Oberg; M Björeman; Magnus Björkholm; Gösta Gahrton; Robert Hast; A Killander; Ingemar Turesson; A M Udén; O Vikrot
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.
Leukemia & lymphoma 1992;7 Suppl():55-7.
1991: Gudmar Lönnerholm; Kristina Carlson; L E Bratteby; L Bäcklund; H Hagberg; G Rikner; B Smedmyr; Gunnar Oberg; Bengt Simonsson
Renal function after autologous bone marrow transplantation.
Bone marrow transplantation 1991;8(2):129-34.
1991: B Smedmyr; M Bengtsson; A Jakobsson; Bengt Simonsson; Gunnar Oberg; Thomas H Tötterman
Regeneration of CALLA (CD10+), TdT+ and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation.
European journal of haematology 1991;46(3):146-51.
1991: M Hassan; Gunnar Oberg; A N Bekassy; Johan Aschan; Hans Ehrsson; P Ljungman; G Lönnerholm; B Smedmyr; A Taube; Inger Wallin
Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology.
Cancer chemotherapy and pharmacology 1991;28(2):130-4.
1990: E Hellström; K H Robèrt; Jan Samuelsson; C Lindemalm; Gunnar Grimfors; Eva Kimby; Gunnar Oberg; I Winqvist; R Billström; Jan Carneskog
Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG).
European journal of haematology 1990;45(5):255-61.
1990: B Smedmyr; L Wibell; Bengt Simonsson; Gunnar Oberg
Impaired glucose tolerance after autologous bone marrow transplantation.
Bone marrow transplantation 1990;6(2):89-92.
1989: M Bengtsson; J Gordon; L Flores-Romo; J A Cairns; B Smedmyr; Gunnar Oberg; B Simonsson; Thomas H Tötterman
B-cell reconstitution after autologous bone marrow transplantation: increase in serum CD23 ("IgE-binding factor") precedes IgE and B-cell regeneration.
Blood 1989;73(8):2139-44.
1989: M Hassan; Gunnar Oberg; Hans Ehrsson; M Ehrnebo; Inger Wallin; B Smedmyr; T Tötterman; Staffan Eksborg; Bengt Simonsson
Pharmacokinetic and metabolic studies of high-dose busulphan in adults.
European journal of clinical pharmacology 1989;36(5):525-30.
1989: M Hassan; Hans Ehrsson; B Smedmyr; T Tötterman; Inger Wallin; Gunnar Oberg; Bengt Simonsson
Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy.
Bone marrow transplantation 1989;4(1):113-4.
1989: M Bengtsson; Thomas H Tötterman; B Smedmyr; R Festin; Gunnar Oberg; Bengt Simonsson
Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis.
Leukemia 1989;3(1):68-75.
1989: M Bengtsson; B Smedmyr; R Festin; Gunnar Oberg; B Simonsson; Thomas H Tötterman
B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: increased numbers of B cells carrying activation and progression markers.
Leukemia research 1989;13(9):791-7.
1988: M Bengtsson; B Smedmyr; Bengt Simonsson; Gunnar Oberg; G Lönnerholm; Thomas H Tötterman
Repopulation of T, B, and natural killer-like cells in the blood and marrow after purged autologous bone marrow transplantation.
Transplantation proceedings 1988;20(3):506-9.
1988: Thomas H Tötterman; M Carlsson; S Funderud; B Simonsson; Gunnar Oberg; K Nilsson
Chronic B-lymphocytic leukemia--expression of B cell activation markers in relation to activity of the disease.
Nouvelle revue française d'hématologie 1988;30(5-6):279-81.
1988: Per Hartvig; Bengt Simonsson; Gunnar Oberg; Inger Wallin; Hans Ehrsson
Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.
European journal of clinical pharmacology 1988;35(5):551-4.
1987: Gunnar Oberg; Bengt Simonsson; B Smedmyr; T H Tötterman; P Venge
Myeloid regeneration after bone-marrow transplantation monitored by serum measurements of myeloperoxidase, lysozyme and lactoferrin.
European journal of haematology 1987;38(4):356-62.
1984: H Hagberg; Jan Simon Gronowitz; A Killander; Clas F R Källander; Bengt Simonsson; Christer Sundström; Gunnar Oberg
Serum thymidine kinase in acute leukaemia.
British journal of cancer 1984;49(4):537-40.
1984: Hans Ehrsson; Inger Wallin; Bengt Simonsson; Per Hartvig; Gunnar Oberg
Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard.
European journal of clinical pharmacology 1984;27(1):111-4.
1982: B Lönnqvist; B Andersson; Magnus Björkholm; L Engstedt; Gösta Gahrton; Robert Hast; G Holm; A Killander; B Lantz; D Lockner; Håkan Mellstedt; Jan Palmblad; C Paul; C Peterson; Bengt Simonsson; A M Stalfelt; A M Udén; B Wadman; Gunnar Oberg
Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.
Cancer chemotherapy and pharmacology 1982;9(2):89-92.
1981: C Paul; Magnus Björkholm; I Christenson; L Engstedt; Gösta Gahrton; Robert Hast; G Holm; A Killander; B Lantz; D Lockner; B Lönnqvist; Håkan Mellstedt; Jan Palmblad; C Peterson; Bengt Simonsson; A M Stalfelt; A M Udén; B Wadman; Gunnar Oberg
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.
Cancer chemotherapy and pharmacology 1981;6(1):65-73.